Carl F. Beyer

Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

Philip R. Hamann, Lois M. Hinman, Irwin Hollander et al. · Bioconjugate Chemistry · 2001 · 587 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker

Philip R. Hamann, Lois M. Hinman, Carl F. Beyer et al. · Bioconjugate Chemistry · 2001 · 227 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and SAR of [1,2,4]Triazolo[1,5-<i>a</i>]pyrimidines, a Class of Anticancer Agents with a Unique Mechanism of Tubulin Inhibition

Nan Zhang, Semiramis Ayral‐Kaloustian, Thai Nguyen et al. · Journal of Medicinal Chemistry · 2006 · 211 citations

Medicine, Medicinal Chemistry, Pharmacology +13

HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.

Frank Loganzo, Carolyn Discafani, Tami Annable et al. · PubMed · 2003 · 137 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes.

Wolfgang E. F. Klinkert, Jon Henry LaBadie, James P. O'Brien et al. · Proceedings of the National Academy of Sciences · 1980 · 128 citations · Full text

Life Sciences, Cell Biology, Immunology +12